The Senate Finance Committee was divided along party lines late last week on the nominee to head the Centers for Medicare and Medicaid Services (CMS).
More news for Monday, June 7
By
Kimberly Bonvissuto
Jun 07, 2021
Empire State bill would require assisted living to collect information on veteran status … NY adopts Essential Caregivers Act, allowing personal caregiving visits in assisted living … TX to consider...
Single dose of zilebesiran linked to reduction in systolic BP
Feb 20, 2024
A significant reduction was seen in systolic blood pressure with zilebesiran 150, 300 or 600 mg once in six months and 300 mg once every three months.
Opioid Rx down for chronic noncancer pain, cancer pain in U.S. adults
Aug 15, 2022
Declines in opioid prescribing are outpacing increases in the receipt of nonopioid therapies.
Diet to induce weight loss can reduce blood pressure in Type 2 diabetes
Jun 04, 2021
69 of 78 participants on treatment for hypertension stopped all or some antihypertensive and diuretic meds.
Links between genetic risk, glaucoma prevalence examined
Jul 23, 2021
Polygenic variants are associated with comparable risk for developing open-angle glaucoma as that associated with the most common single-gene pathogenic variant, according to a study published online July...
Mirtazapine does not reduce agitation in dementia patients
Nov 03, 2021
In a randomized, double-blind trial, no difference was seen in scores for agitated behaviors at 12 weeks with mirtazapine versus placebo.
New tool can predict individual’s dementia risk
Nov 18, 2022
The risk score model yielded almost 100% prediction accuracy of 13-year dementia risk.
Exercise may cut worry of active surveillance for prostate cancer
Mar 14, 2022
A supervised high-intensity interval training program was tied to reductions in anxiety, fear of progression, hormonal symptoms, stress and fatigue.
Dupilumab tied to fewer exacerbations in COPD with type 2 inflammation
May 21, 2024
An increase was seen in prebronchodilator forced expiratory volume in one second with dupilumab versus placebo at weeks 12 and 52.